Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Bruce Abell

Surgery Washington, DC Medical Doctor

NPI 1801869896 CMS profile 172355

2150 Pennsylvania Ave Nw, Washington, DC 20037

Open in the dashboard

General payments

$35,666

39 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Bruce Abell of Washington, DC is reported in the CMS Open Payments database as having received $35,666 across 39 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $30 1
2020 General $10,690 12
2019 General $24,945 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bruce Abell
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Bruce Abell were reported at $0. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Bruce Abell Surgery median Middle half National median
2019 $24,945 $253 $82–$1,521 $163
2020 $10,690 $131 $40–$706 $114
2021 $30 $168 $50–$904 $132
2022 $0 $224 $76–$1,218 $149
2023 $0 $253 $82–$1,255 $160
2024 $0 $279 $90–$1,381 $164
2025 $0 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. TELA Bio, Inc. $18,337 14 payments
  2. Merck Sharp & Dohme Corporation $17,275 23 payments
  3. Integra LifeSciences Corporation $54 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Consulting Fee $16,969 7 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,120 6 payments
  3. Travel and Lodging $2,670 16 payments
  4. Food and Beverage $907 10 payments
Products named General payments · program years 2019–2021
  1. OviTex $18,337 14 payments
  2. ZERBAXA $17,275 23 payments
  3. SURGIMEND Recon-Skin And Wound $30 1 payment
  4. SURGIMEND Recon-Skin And Wound $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$124,259

Medicare's payments for the services billed

Medicare patients

254

Average age 72

Services billed

859

137 women, 117 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Ischemic heart disease 52%
Diabetes 47%
Chronic kidney disease 43%
Heart failure 38%
Atrial fibrillation 37%
COPD 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

39 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record